Heatwurx (PCSA) Competitors $0.21 +0.00 (+0.38%) Closing price 04:00 PM EasternExtended Trading$0.21 -0.01 (-2.82%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock PCSA vs. LSB, GLYC, GNPX, TLPH, DWTX, ADXN, AEON, APRE, KPRX, and IMNNShould you be buying Heatwurx stock or one of its competitors? The main competitors of Heatwurx include LakeShore Biopharma (LSB), GlycoMimetics (GLYC), Genprex (GNPX), Talphera (TLPH), Dogwood Therapeutics (DWTX), Addex Therapeutics (ADXN), AEON Biopharma (AEON), Aprea Therapeutics (APRE), Kiora Pharmaceuticals (KPRX), and Imunon (IMNN). These companies are all part of the "pharmaceutical products" industry. Heatwurx vs. Its Competitors LakeShore Biopharma GlycoMimetics Genprex Talphera Dogwood Therapeutics Addex Therapeutics AEON Biopharma Aprea Therapeutics Kiora Pharmaceuticals Imunon Heatwurx (NASDAQ:PCSA) and LakeShore Biopharma (NASDAQ:LSB) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings. Which has more risk and volatility, PCSA or LSB? Heatwurx has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500. Comparatively, LakeShore Biopharma has a beta of 0.58, suggesting that its stock price is 42% less volatile than the S&P 500. Which has stronger valuation & earnings, PCSA or LSB? Heatwurx has higher earnings, but lower revenue than LakeShore Biopharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeatwurxN/AN/A-$11.85M-$3.08-0.07LakeShore Biopharma$80.82MN/A-$61.09MN/AN/A Is PCSA or LSB more profitable? LakeShore Biopharma's return on equity of 0.00% beat Heatwurx's return on equity.Company Net Margins Return on Equity Return on Assets HeatwurxN/A -319.56% -232.40% LakeShore Biopharma N/A N/A N/A Do institutionals & insiders have more ownership in PCSA or LSB? 91.9% of Heatwurx shares are owned by institutional investors. Comparatively, 52.6% of LakeShore Biopharma shares are owned by institutional investors. 9.6% of Heatwurx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts recommend PCSA or LSB? Heatwurx presently has a consensus target price of $2.00, indicating a potential upside of 838.97%. Given Heatwurx's stronger consensus rating and higher probable upside, analysts plainly believe Heatwurx is more favorable than LakeShore Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Heatwurx 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00LakeShore Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer PCSA or LSB? In the previous week, Heatwurx's average media sentiment score of 1.89 beat LakeShore Biopharma's score of 1.25 indicating that Heatwurx is being referred to more favorably in the media. Company Overall Sentiment Heatwurx Very Positive LakeShore Biopharma Positive SummaryHeatwurx beats LakeShore Biopharma on 8 of the 11 factors compared between the two stocks. Get Heatwurx News Delivered to You Automatically Sign up to receive the latest news and ratings for PCSA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PCSA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PCSA vs. The Competition Export to ExcelMetricHeatwurxMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.52M$2.46B$5.54B$9.41BDividend YieldN/A1.80%3.75%4.03%P/E RatioN/A4.4521.0120.09Price / SalesN/A709.89433.8199.01Price / CashN/A164.7736.1658.27Price / Book0.465.008.125.65Net Income-$11.85M$30.99M$3.25B$257.91M7 Day Performance-5.84%1.69%0.97%2.09%1 Month Performance-11.98%9.20%7.36%11.13%1 Year Performance-87.01%-1.25%31.31%18.40% Heatwurx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PCSAHeatwurx3.048 of 5 stars$0.21+0.4%$2.00+839.0%-87.6%$2.52MN/A0.0020LSBLakeShore Biopharma0.8199 of 5 stars$1.11+2.8%N/A-76.3%$10.05M$80.82M0.00773Positive NewsGap DownGLYCGlycoMimeticsN/A$0.16-6.6%N/A-99.5%$10.00M$10K-0.3450High Trading VolumeGNPXGenprex1.3581 of 5 stars$0.30+8.3%N/A-85.8%$9.95MN/A0.0020TLPHTalphera2.4028 of 5 stars$0.47-8.9%$5.00+955.1%-53.3%$9.72M$27K-1.0519Positive NewsHigh Trading VolumeDWTXDogwood Therapeutics1.717 of 5 stars$5.08+6.7%$10.00+96.9%N/A$9.71MN/A-0.285ADXNAddex Therapeutics2.4098 of 5 stars$9.02+2.2%$30.00+232.4%+2.4%$9.57M$460K-26.5430News CoveragePositive NewsAEONAEON Biopharma2.4476 of 5 stars$0.83-0.7%$360.00+43,039.6%-99.6%$9.43MN/A4.645Gap DownAPREAprea Therapeutics2.9391 of 5 stars$1.70-1.7%$15.50+811.8%-58.1%$9.40M$1.50M-0.727Positive NewsGap UpKPRXKiora Pharmaceuticals3.2944 of 5 stars$3.08+2.7%$10.00+224.7%-28.0%$9.38MN/A-1.0610IMNNImunon2.1308 of 5 stars$0.52-14.1%$15.50+2,880.8%-58.4%$9.12MN/A-0.3830Positive News Related Companies and Tools Related Companies LakeShore Biopharma Alternatives GlycoMimetics Alternatives Genprex Alternatives Talphera Alternatives Dogwood Therapeutics Alternatives Addex Therapeutics Alternatives AEON Biopharma Alternatives Aprea Therapeutics Alternatives Kiora Pharmaceuticals Alternatives Imunon Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PCSA) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heatwurx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heatwurx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.